IART
HealthcareIntegra LifeSciences Holdings Corporation
$12.56
+$0.55 (+4.58%)
Jan 5, 2026
Price History (1Y)
Analysis
Integra LifeSciences Holdings Corporation is a healthcare company operating in the medical devices industry. The firm has a market capitalization of $978.56M, annual revenue of $1.64B, and employs 4396 individuals. The company's financial health indicates significant net income losses, with a net loss of -$495.33M in the trailing twelve months. Its profitability metrics are mixed: gross margin stands at 57.5%, while operating margin is 9.9% and profit margin is -30.1%. Returns on equity and assets are -38.7% and 2.6%, respectively, reflecting significant losses compared to earnings from assets. The balance sheet shows a debt-to-equity ratio of 193.50, indicating substantial leverage, while cash reserves total $267.88M. Integra LifeSciences Holdings Corporation's valuation metrics include a forward P/E of 5.34 and an EV/EBITDA of 8.39. Revenue growth has been 5.6% year-over-year, though earnings growth is not available due to net losses. The company does not pay dividends.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Visit website →Key Statistics
- Market Cap
- $978.56M
- P/E Ratio
- N/A
- 52-Week High
- $27.13
- 52-Week Low
- $10.87
- Avg Volume
- 968.59K
- Beta
- 1.03
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United States
- Employees
- 4,396